ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,376Medicare Part D Prescriptions Filled, Including Refills

Rank: 43 out of 337

$574K Total Retail Price of All Prescriptions

Rank: 52 out of 337

397 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 397 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 397 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

4% of this provider’s 10,536 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
METOPROLOL TARTRATE 665 580 1 6
SIMVASTATIN 659 513 2 1
FUROSEMIDE 549 506 3 8
ATORVASTATIN CALCIUM 471 418 4 7
OMEPRAZOLE 426 385 5 4
AMLODIPINE BESYLATE 402 392 6 3
LISINOPRIL 401 319 7 2
HYDROCODONE-ACETAMINOPHEN 329 250 S3 8 13
LEVOTHYROXINE SODIUM 289 258 9 5
METOPROLOL SUCCINATE 240 211 10 21
GLYBURIDE 230 204 R 11 53
LISINOPRIL-HYDROCHLOROTHIAZIDE 228 204 12 31
METFORMIN HCL 223 186 13 12
ATENOLOL 222 222 14 10
DOXAZOSIN MESYLATE 173 161 15 68
LOVASTATIN 164 151 16 24
SERTRALINE HCL 133 83 17 18
WARFARIN SODIUM 127 107 18 11
RANITIDINE HCL 125 81 19 30
HYDROCHLOROTHIAZIDE 119 106 20 9
LIPITOR 117 105 21 33
QUINAPRIL HCL 117 103 21 50
GLYBURIDE-METFORMIN HCL 112 100 R 23 99
ALENDRONATE SODIUM 110 86 24 19
ZOLPIDEM TARTRATE 107 55 25 23
LOSARTAN-HYDROCHLOROTHIAZIDE 105 92 26 60
PROAIR HFA 105 92 26 38
CLOPIDOGREL 102 88 28 42
TRAMADOL HCL 92 64 29 32
ENALAPRIL MALEATE 92 82 29 37
CARVEDILOL 90 80 31 73
CITALOPRAM HBR 85 74 32 17
ISOSORBIDE MONONITRATE ER 84 84 33 70
TRAMADOL HCL-ACETAMINOPHEN 83 72 34 173
NEXIUM 79 35 35 56
LOSARTAN POTASSIUM 78 74 36 15
SYNTHROID 77 69 37 41
LORAZEPAM 76 76 38 119
ALLOPURINOL 74 74 39 28
TAMSULOSIN HCL 74 64 39 25
PLAVIX 72 66 41 74
INSULIN SYRINGE 71 59 42 127
GABAPENTIN 69 67 43 20
FLUOXETINE HCL 68 38 44 57
SPIRIVA 68 60 44 43
PRAVASTATIN SODIUM 64 56 46 14
TRIAMTERENE-HCTZ 64 64 46 39
GLIPIZIDE 62 55 48 45
ADVAIR DISKUS 62 53 48 44
DIGOXIN 61 57 50 58
CRESTOR 61 46 50 29
TRAZODONE HCL 60 45 52 16
HYDRALAZINE HCL 60 57 52 122
DIOVAN 60 52 52 26
LANTUS SOLOSTAR 59 56 55 146
IBUPROFEN 59 42 55 64
EVISTA 59 59 55 102
LEVOXYL 56 56 58 90
CELEBREX 54 42 59 116
POTASSIUM CHLORIDE 52 41 60 62
CAPTOPRIL 52 51 60 204
CLONIDINE HCL 52 40 60 135
NIFEDIPINE ER 52 52 60 111
FLUTICASONE PROPIONATE 51 38 64 34
KLOR-CON M20 51 51 64 65
LANTUS 51 26 64 49
ALPRAZOLAM 51 42 64 78
DIOVAN HCT 50 43 68 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.